NCT02576847View on ClinicalTrials.gov

Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

PHASE3CompletedINTERVENTIONAL

Enrollment

307

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

July 14, 2017

Study Completion Date

February 8, 2018

Conditions

Rosacea

Interventions

DRUG

Omiganan

Topical gel

Trial Locations (28)

Unknown

Fremont

Miami

Miramar

Tampa

Arlington Heights

Carmel

Indianapolis

Plainfield

Watertown

Albuquerque

New York

Nashville

Dallas

Pflugerville

Webster

Sydney

Woolloongabba

Vancouver

Winnipeg

Drummondville

Cannes

Nice

Bergen op Zoom

Hamilton

Wellington

Gothenburg

Lanarkshire

Manchester

All Listed Sponsors

lead

Maruho Co., Ltd.

INDUSTRY

NCT02576847 - Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel | Biotech Hunter | Biotech Hunter